or Try an Advanced Search...

    Technical Analysis for TBPH - Theravance Biopharma, Inc.

    Grade Last Price % Change Price Change
    B 9.17 -0.54% -0.05
    TBPH closed down 0.54 percent on Wednesday, April 24, 2024, on 78 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 6
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical TBPH trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Fell Below 20 DMA Bearish -0.54%
    MACD Bearish Signal Line Cross Bearish -0.54%
    Outside Day Range Expansion -0.54%
    20 DMA Support Bullish -3.07%
    NR7 Range Contraction -3.07%
    Crossed Above 20 DMA Bullish -1.82%
    Fell Below 20 DMA Bearish -0.33%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.33%
    Down 3 Days in a Row Weakness -0.33%
    Older End-of-Day Signals for TBPH ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 19 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    Down 1% about 23 hours ago
    Fell Below Previous Day's Low about 23 hours ago
    Outside Day 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TBPH Chart by TradingView
    Basic chart:

    Profile

    Theravance Biopharma, Inc. operates as a biopharmaceutical company. It provides discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company is based in George Town, Cayman Islands. Theravance Biopharma, Inc. operates as a subsidiary of Theravance Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pain Medication Respiratory Diseases Bacterial Infections

    Is TBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 15 BTIG Research Predicts Over 118% Rally for These 3 Stocks
    Apr 15 Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
    Apr 10 Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
    Apr 3 Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
    Mar 27 Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
    Mar 12 Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
    Feb 28 Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript
    Feb 27 Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
    Feb 27 Theravance Biopharma, Inc. (TBPH) Q4 2023 Earnings Call Transcript
    Feb 27 Theravance Biopharma, Inc. 2023 Q4 - Results - Earnings Call Presentation
    See more TBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.98
    52 Week Low 8.21
    Average Volume 378,616
    200-Day Moving Average 9.62
    50-Day Moving Average 9.04
    20-Day Moving Average 9.32
    10-Day Moving Average 9.41
    Average True Range 0.39
    RSI (14) 48.45
    ADX 23.11
    +DI 21.19
    -DI 17.78
    Chandelier Exit (Long, 3 ATRs) 9.26
    Chandelier Exit (Short, 3 ATRs) 9.83
    Upper Bollinger Bands 9.83
    Lower Bollinger Band 8.81
    Percent B (%b) 0.35
    BandWidth 11.03
    MACD Line 0.08
    MACD Signal Line 0.11
    MACD Histogram -0.0334
    Fundamentals Value
    Market Cap 456.65 Million
    Num Shares 49.8 Million
    EPS -1.03
    Price-to-Earnings (P/E) Ratio -8.90
    Price-to-Sales 7.89
    Price-to-Book 1.74
    PEG Ratio -0.05
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.49
    Resistance 3 (R3) 9.48 9.37 9.43
    Resistance 2 (R2) 9.37 9.29 9.37 9.41
    Resistance 1 (R1) 9.27 9.24 9.32 9.28 9.40
    Pivot Point 9.16 9.16 9.19 9.16 9.16
    Support 1 (S1) 9.06 9.08 9.11 9.07 8.94
    Support 2 (S2) 8.95 9.03 8.95 8.93
    Support 3 (S3) 8.85 8.95 8.91
    Support 4 (S4) 8.86